Table 6.
Clinical outcomes | Early UST use (n = 105) | Late UST use (n = 132) | p Value |
---|---|---|---|
Composite outcome, n (%) | 16 (15.2) | 51 (38.6) | <0.001 |
Hospitalization, n (%) | 13 (12.4) | 39 (29.5) | 0.002 |
Treatment escalation, n (%) | 7 (6.7) | 30 (22.7) | <0.001 |
Behavior progression, n (%) | 10 (9.5) | 19 (14.4) | 0.256 |
CD-related surgeries, n (%) | 7 (6.7) | 11 (8.3) | 0.630 |
CD, Crohn’s disease; UST, Ustekinumab.